NU SKIN ENTERPRISES INC - A (NUS) Stock Fundamental Analysis
USA - NYSE:NUS - US67018T1051 - Common Stock
9.53 USD
-0.34 (-3.44%)
Taking everything into account, NUS scores 5 out of 10 in our fundamental rating. NUS was compared to 34 industry peers in the Personal Care Products industry. While NUS has a great health rating, its profitability is only average at the moment. NUS has a bad growth rate and is valued cheaply.
1. Profitability
1.1 Basic Checks
NUS had positive earnings in the past year.
NUS had a positive operating cash flow in the past year.
NUS had positive earnings in 4 of the past 5 years.
In the past 5 years NUS always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of NUS (6.98%) is better than 70.59% of its industry peers.
The Return On Equity of NUS (12.80%) is better than 79.41% of its industry peers.
NUS has a Return On Invested Capital (3.88%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for NUS is significantly below the industry average of 12.99%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.98% | ||
| ROE | 12.8% | ||
| ROIC | 3.88% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
1.3 Margins
NUS has a better Profit Margin (6.20%) than 73.53% of its industry peers.
NUS has a Operating Margin (3.51%) which is in line with its industry peers.
In the last couple of years the Operating Margin of NUS has declined.
NUS has a Gross Margin (67.23%) which is in line with its industry peers.
NUS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.51% | ||
| PM (TTM) | 6.2% | ||
| GM | 67.23% |
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NUS is destroying value.
Compared to 1 year ago, NUS has more shares outstanding
NUS has less shares outstanding than it did 5 years ago.
The debt/assets ratio for NUS has been reduced compared to a year ago.
2.2 Solvency
NUS has an Altman-Z score of 3.72. This indicates that NUS is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.72, NUS is in the better half of the industry, outperforming 73.53% of the companies in the same industry.
The Debt to FCF ratio of NUS is 0.61, which is an excellent value as it means it would take NUS, only 0.61 years of fcf income to pay off all of its debts.
NUS's Debt to FCF ratio of 0.61 is amongst the best of the industry. NUS outperforms 88.24% of its industry peers.
NUS has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
NUS has a Debt to Equity ratio (0.27) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 0.61 | ||
| Altman-Z | 3.72 |
ROIC/WACC0.52
WACC7.47%
2.3 Liquidity
A Current Ratio of 2.01 indicates that NUS has no problem at all paying its short term obligations.
NUS has a Current ratio of 2.01. This is comparable to the rest of the industry: NUS outperforms 50.00% of its industry peers.
NUS has a Quick Ratio of 1.38. This is a normal value and indicates that NUS is financially healthy and should not expect problems in meeting its short term obligations.
NUS has a Quick ratio (1.38) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.01 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 64.29% over the past year.
The earnings per share for NUS have been decreasing by -22.85% on average. This is quite bad
NUS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.04%.
NUS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.47% yearly.
EPS 1Y (TTM)64.29%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%100%
Revenue 1Y (TTM)-12.04%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-15.33%
3.2 Future
The Earnings Per Share is expected to grow by 36.15% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -5.71% on average over the next years.
EPS Next Y49.72%
EPS Next 2Y36.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.95%
Revenue Next 2Y-5.71%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 6.91, the valuation of NUS can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of NUS indicates a rather cheap valuation: NUS is cheaper than 94.12% of the companies listed in the same industry.
NUS is valuated cheaply when we compare the Price/Earnings ratio to 26.28, which is the current average of the S&P500 Index.
NUS is valuated cheaply with a Price/Forward Earnings ratio of 6.05.
Based on the Price/Forward Earnings ratio, NUS is valued cheaper than 94.12% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 33.61, NUS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.91 | ||
| Fwd PE | 6.05 |
4.2 Price Multiples
91.18% of the companies in the same industry are more expensive than NUS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, NUS is valued cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.15 | ||
| EV/EBITDA | 3.99 |
4.3 Compensation for Growth
NUS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NUS's earnings are expected to grow with 36.15% in the coming years.
PEG (NY)0.14
PEG (5Y)N/A
EPS Next 2Y36.15%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.43%, NUS has a reasonable but not impressive dividend return.
NUS's Dividend Yield is a higher than the industry average which is at 6.51.
NUS's Dividend Yield is comparable with the S&P500 average which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.43% |
5.2 History
The dividend of NUS decreases each year by -30.50%.
NUS has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-30.5%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
11.83% of the earnings are spent on dividend by NUS. This is a low number and sustainable payout ratio.
DP11.83%
EPS Next 2Y36.15%
EPS Next 3YN/A
NYSE:NUS (11/11/2025, 3:05:58 PM)
9.53
-0.34 (-3.44%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners75.02%
Inst Owner Change-0.67%
Ins Owners2.08%
Ins Owner Change3.24%
Market Cap471.73M
Revenue(TTM)1.73B
Net Income(TTM)100.83M
Analysts45
Price Target7.65 (-19.73%)
Short Float %4.5%
Short Ratio3.99
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.43% |
Yearly Dividend0.24
Dividend Growth(5Y)-30.5%
DP11.83%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.8%
Min EPS beat(2)73.77%
Max EPS beat(2)73.83%
EPS beat(4)3
Avg EPS beat(4)52.6%
Min EPS beat(4)-13.83%
Max EPS beat(4)76.64%
EPS beat(8)6
Avg EPS beat(8)40.86%
EPS beat(12)9
Avg EPS beat(12)30.24%
EPS beat(16)13
Avg EPS beat(16)24.81%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.5%
Max Revenue beat(2)2.51%
Revenue beat(4)3
Avg Revenue beat(4)0.44%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)2.51%
Revenue beat(8)5
Avg Revenue beat(8)-0.53%
Revenue beat(12)5
Avg Revenue beat(12)-1.53%
Revenue beat(16)7
Avg Revenue beat(16)-1.15%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.9%
EPS NY rev (1m)0%
EPS NY rev (3m)27.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.91 | ||
| Fwd PE | 6.05 | ||
| P/S | 0.29 | ||
| P/FCF | 1.15 | ||
| P/OCF | 1.06 | ||
| P/B | 0.6 | ||
| P/tB | 0.72 | ||
| EV/EBITDA | 3.99 |
EPS(TTM)1.38
EY14.48%
EPS(NY)1.58
Fwd EY16.53%
FCF(TTM)8.3
FCFY87.11%
OCF(TTM)9
OCFY94.49%
SpS32.86
BVpS15.91
TBVpS13.3
PEG (NY)0.14
PEG (5Y)N/A
Graham Number22.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.98% | ||
| ROE | 12.8% | ||
| ROCE | 4.92% | ||
| ROIC | 3.88% | ||
| ROICexc | 5.04% | ||
| ROICexgc | 5.89% | ||
| OM | 3.51% | ||
| PM (TTM) | 6.2% | ||
| GM | 67.23% | ||
| FCFM | 25.27% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
ROICexc(3y)6.41%
ROICexc(5y)12.52%
ROICexgc(3y)8.32%
ROICexgc(5y)17.24%
ROCE(3y)6.61%
ROCE(5y)11.76%
ROICexgc growth 3Y-45.58%
ROICexgc growth 5Y-28.67%
ROICexc growth 3Y-42.83%
ROICexc growth 5Y-26.9%
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
F-Score6
Asset Turnover1.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 0.61 | ||
| Debt/EBITDA | 1.81 | ||
| Cap/Depr | 56.99% | ||
| Cap/Sales | 2.14% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 377.59% | ||
| Profit Quality | 407.56% | ||
| Current Ratio | 2.01 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 3.72 |
F-Score6
WACC7.47%
ROIC/WACC0.52
Cap/Depr(3y)74.52%
Cap/Depr(5y)79.94%
Cap/Sales(3y)2.68%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.29%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%100%
EPS Next Y49.72%
EPS Next 2Y36.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.04%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-15.33%
Revenue Next Year-11.95%
Revenue Next 2Y-5.71%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y44.66%
EBIT growth 3Y-43.79%
EBIT growth 5Y-28.27%
EBIT Next Year155.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21528.6%
FCF growth 3Y-1.31%
FCF growth 5Y-8.9%
OCF growth 1Y561.31%
OCF growth 3Y-7.59%
OCF growth 5Y-8.88%
NU SKIN ENTERPRISES INC - A / NUS FAQ
Can you provide the ChartMill fundamental rating for NU SKIN ENTERPRISES INC - A?
ChartMill assigns a fundamental rating of 5 / 10 to NUS.
Can you provide the valuation status for NU SKIN ENTERPRISES INC - A?
ChartMill assigns a valuation rating of 9 / 10 to NU SKIN ENTERPRISES INC - A (NUS). This can be considered as Undervalued.
Can you provide the profitability details for NU SKIN ENTERPRISES INC - A?
NU SKIN ENTERPRISES INC - A (NUS) has a profitability rating of 4 / 10.
What is the valuation of NU SKIN ENTERPRISES INC - A based on its PE and PB ratios?
The Price/Earnings (PE) ratio for NU SKIN ENTERPRISES INC - A (NUS) is 6.91 and the Price/Book (PB) ratio is 0.6.
Is the dividend of NU SKIN ENTERPRISES INC - A sustainable?
The dividend rating of NU SKIN ENTERPRISES INC - A (NUS) is 4 / 10 and the dividend payout ratio is 11.83%.